Bleeding Disorder News and Research

RSS
Study outlines agenda to help direct future caffeine dependence research

Study outlines agenda to help direct future caffeine dependence research

CHOP scientist receives 2013 E. Donnall Thomas Prize for scientific, clinical research in hemophilia

CHOP scientist receives 2013 E. Donnall Thomas Prize for scientific, clinical research in hemophilia

CHOP scientist receives 2013 E. Donnall Thomas Prize for research in bleeding disorder hemophilia

CHOP scientist receives 2013 E. Donnall Thomas Prize for research in bleeding disorder hemophilia

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

New smartphone app for patients with hemophilia and related bleeding disorders

New smartphone app for patients with hemophilia and related bleeding disorders

UTHealth researchers find cause for rare type of bleeding disorder

UTHealth researchers find cause for rare type of bleeding disorder

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

CHOP-led research increases numbers of patients who could be treated with gene therapy

CHOP-led research increases numbers of patients who could be treated with gene therapy

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

Study sheds light on stem cell technique for treatment of common bleeding disorder

Study sheds light on stem cell technique for treatment of common bleeding disorder

Cardiovascular disease risk in women higher than you think

Cardiovascular disease risk in women higher than you think

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Bayer completes recruitment of first cohort for BAY 86-6150 Phase II/III study in hemophilia

Bayer completes recruitment of first cohort for BAY 86-6150 Phase II/III study in hemophilia

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Inspiration, Ipsen receive FDA Fast Track designation for OBI-1 to treat AHA

Inspiration, Ipsen receive FDA Fast Track designation for OBI-1 to treat AHA

Hemostatic testing may explain heavy menstrual bleeding

Hemostatic testing may explain heavy menstrual bleeding

Pfizer Hemophilia donates more than 35M IUs of recombinant factor IX therapy to WFH

Pfizer Hemophilia donates more than 35M IUs of recombinant factor IX therapy to WFH

Physical activity associated with increased risk of bleeding in children with hemophilia

Physical activity associated with increased risk of bleeding in children with hemophilia

Dexamethasone use during tonsillectomy not associated with excessive bleeding in children

Dexamethasone use during tonsillectomy not associated with excessive bleeding in children

Roundup: Ore. insurance CO-OP readies coverage; N.J. Medicaid liabilities hurt state's fiscal outlook; Wis. AG appeals collective bargaining ruling

Roundup: Ore. insurance CO-OP readies coverage; N.J. Medicaid liabilities hurt state's fiscal outlook; Wis. AG appeals collective bargaining ruling